DHN-88013-41449

Timeline

1. 2021-04-06
   Dose 1 — Pfizer-BioNTech
2. 2021-04-11
   Registered in v-safe
3. 2021-04-11
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · None

   Adult check-in
4. 2021-04-27
   Dose 2 — Pfizer-BioNTech
5. 2021-04-27
   Survey response — day 0, dose 2

   MedDRA: Dyspnoea, Hyperhidrosis, Loss of consciousness, Panic attack — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

   Free text: Sweating, loss of consciousness, shortness of breath. Panic attack.

   MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
6. 2021-04-28
   Health check-in — days 1–6 daily, dose 2

   Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activities

   Adult check-in
7. 2021-04-29
   Health check-in — days 1–6 daily, dose 2

   Feeling: Good · Site: Pain · None

   Adult check-in
8. 2021-04-30
   Health check-in — days 1–6 daily, dose 2

   Feeling: Good · Site: Pain · None

   Adult check-in
9. 2021-10-26
   Survey response — 6 months, dose 2

   MedDRA: Herpes zoster — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

   Free text: Shingles

   MedDRA releases: 2024-11 · check-in free text available
10. 2021-10-26
    Report sent to call center — 6 months, dose 2

    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
11. 2021-10-27
    Call successful

    Participant prefers to complete VAERS report online